Clinical Trial Update: The Safety and Efficacy Study of Ethylenediaminetetraacetic Acid (EDTA) Ophthalmic Solution in Patients With Loss of Contrast Sensitivity Due to Age-Related, Low-Grade Nuclear Cataract [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update on EDTA ophthalmic solution for age-related cataracts, focusing on safety and efficacy in patients with low-grade nuclear cataract and los…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Cataract
• Nuclear Cataract

Drugs mentioned

• Ethylenediaminetetraacetic Acid ophthalmic solution (EthyleneDiamineTetraacetic Acid)

Snippet

Sponsor: Livionex Inc. | Conditions: Age Related Cataracts | Phase 1, Phase 2 | Status: COMPLETED